Literature DB >> 15582844

Neuropsychological change following gamma knife surgery in patients with left temporal lobe epilepsy: a review of three cases.

Carrie R McDonald1, Marc A Norman, Evelyn Tecoma, John Alksne, Vicente Iragui.   

Abstract

Gamma knife surgery (GKS) is a radiation procedure recently used in the treatment of temporal lobe epilepsy (TLE). Preliminary studies have shown significant seizure reductions in patients 8-26 months postprocedure; however, little is known about the effect of GKS on cognitive functioning in TLE. We report neuropsychological data on three patients with left TLE and MRI evidence of hippocampal sclerosis who underwent GKS. Two models for assessing cognitive change, reliable change indices and regression-based norms for change, were used to measure preoperative versus 13- to 27-month postoperative cognitive change. Results revealed a significantly long delayed verbal memory decline on one measure following GKS. No patient declined on measures of IQ, visual memory, or language. Radiation-induced edema was present at the time of testing in all three patients, which may have affected verbal memory performance. While preliminary, these data suggest that GKS offers a less invasive option to anterior temporal lobectomy, but may produce neuropsychological changes similar to those produced by left anterior temperol lobectomy up to 2 years post-GKS treatment.

Entities:  

Mesh:

Year:  2004        PMID: 15582844     DOI: 10.1016/j.yebeh.2004.08.014

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  11 in total

1.  Is radiosurgery a neuromodulation therapy? : A 2009 Fabrikant award lecture.

Authors:  Jean Régis; Romain Carron; Michael Park
Journal:  J Neurooncol       Date:  2010-05-29       Impact factor: 4.130

Review 2.  Cognitive functioning following epilepsy surgery.

Authors:  Marla J Hamberger; Evan B Drake
Journal:  Curr Neurol Neurosci Rep       Date:  2006-07       Impact factor: 5.081

Review 3.  Gamma knife for functional diseases.

Authors:  Jean Régis
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

Review 4.  Radiosurgery for epilepsy: clinical experience and potential antiepileptic mechanisms.

Authors:  Mark Quigg; John Rolston; Nicholas M Barbaro
Journal:  Epilepsia       Date:  2011-12-22       Impact factor: 5.864

5.  Neuropsychological outcomes after Gamma Knife radiosurgery for mesial temporal lobe epilepsy: a prospective multicenter study.

Authors:  Mark Quigg; Donna K Broshek; Nicholas M Barbaro; Mariann M Ward; Kenneth D Laxer; Guofen Yan; Kathleen Lamborn
Journal:  Epilepsia       Date:  2011-03-22       Impact factor: 5.864

Review 6.  New Techniques and Progress in Epilepsy Surgery.

Authors:  Robert A McGovern; Garrett P Banks; Guy M McKhann
Journal:  Curr Neurol Neurosci Rep       Date:  2016-07       Impact factor: 5.081

7.  Predictors of efficacy after stereotactic radiosurgery for medial temporal lobe epilepsy.

Authors:  E F Chang; M Quigg; M C Oh; W P Dillon; M M Ward; K D Laxer; D K Broshek; N M Barbaro
Journal:  Neurology       Date:  2010-01-12       Impact factor: 9.910

8.  Morphological changes after radiosurgery for mesial temporal lobe epilepsy.

Authors:  Zdeněk Vojtěch; Hana Malíková; Martin Syrůček; Lenka Krámská; Jan Šroubek; Vilibald Vladyka; Roman Liščák
Journal:  Acta Neurochir (Wien)       Date:  2015-08-16       Impact factor: 2.216

9.  Radiosurgery for the treatment of dominant hemisphere periventricular heterotopia and intractable epilepsy in a series of three patients.

Authors:  Chengyuan Wu; Michael R Sperling; Steven M Falowski; Ameet V Chitale; Maria Werner-Wasik; James J Evans; David W Andrews; Ashwini D Sharan
Journal:  Epilepsy Behav Case Rep       Date:  2012-11-07

10.  Fractionated Stereotactic Gamma Knife Radiosurgery for Medial Temporal Lobe Epilepsy: A Case Report.

Authors:  Hye Ran Park; Hyun-Tai Chung; Sang Kun Lee; Dong Gyu Kim; Sun Ha Paek
Journal:  Exp Neurobiol       Date:  2016-03-31       Impact factor: 3.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.